Replies to post #2929 on ImClone Systems Inc (formerly IMCL)

[bio_guyo]

Being first to file (in Europe) comes with a price. Six months after European applications are submitted, they are published. This often gives key strategic and scientific information to one's competitors, and at an early stage in the drug discovery/development process to boot. In the US, patents only are published when they are issued.